Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Matricardi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Genes, Chromosomes & Cancer|June 20, 2013
Genetic instability of the tumor suppressor gene FHIT in normal human cellsElisa Palumbo, Elena Tosoni, Laura Matricardi, et al.
Chromosoma|June 30, 2010
Replication dynamics at common fragile site FRA6EElisa Palumbo, Laura Matricardi, Elena Tosoni, et al.
Scientific Reports|August 21, 2020
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predispositionSimona Agata, Silvia Tognazzo, Elisa Alducci, et al.
Biochimica Et Biophysica Acta|April 19, 2015
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127Christian Borgo, Cinzia Franchin, Valentina Salizzato, et al.
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
Human Molecular Genetics|July 2, 2015
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorPaolo Peterlongo, Irene Catucci, Mara Colombo, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genes, Chromosomes & Cancer|June 20, 2013
Genetic instability of the tumor suppressor gene FHIT in normal human cellsElisa Palumbo, Elena Tosoni, Laura Matricardi, et al.
Chromosoma|June 30, 2010
Replication dynamics at common fragile site FRA6EElisa Palumbo, Laura Matricardi, Elena Tosoni, et al.
Scientific Reports|August 21, 2020
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predispositionSimona Agata, Silvia Tognazzo, Elisa Alducci, et al.
Biochimica Et Biophysica Acta|April 19, 2015
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127Christian Borgo, Cinzia Franchin, Valentina Salizzato, et al.
Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.
Human Molecular Genetics|July 2, 2015
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorPaolo Peterlongo, Irene Catucci, Mara Colombo, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Pageof 2